Chemical proteomic profiling of protein dopaminylation in colorectal cancer cells
Nan ZhangiD, Shuaixin GaoiD, Haidong Peng, Jinghua WuiD, Huapeng LiiD, Connor Gibson, Sophia WuiD, Jiangjiang ZhuiD, Qingfei ZhengiD
Abstract
Histone dopaminylation is a newly identified epigenetic mark that plays a role in the regulation of gene transcription, where an isopeptide bond is formed between the fifth amino acid residue of H3 (i.e., glutamine) and dopamine. In our previous studies, we discovered that the dynamics of this post-translational modification (including installation, removal, and replacement) were regulated by a single enzyme, transglutaminase 2 (TGM2), through reversible transamination. Recently, we developed a chemical probe to specifically label and enrich histone dopaminylation via bioorthogonal chemistry. Given this powerful tool, we found that histone H3 glutamine 5 dopaminylation (H3Q5dop) was highly enriched in colorectal tumors, which could be attributed to the high expression level of TGM2 in colon cancer cells. Due to the enzyme promiscuity of TGM2, non-histone proteins have also been identified as targets of dopaminylation on glutamine residues, however, the dopaminylated proteome in cancer cells still remains elusive. Here, we utilized our chemical probe to enrich dopaminylated proteins from colorectal cancer cells in a bioorthogonal manner and performed the chemical proteomics analysis. Therefore, 425 dopaminylated proteins were identified, many of which are involved in nucleic acid metabolism and transcription pathways. More importantly, a number of modification sites of these dopaminylated proteins were identified, attributed to the successful application of our chemical probe. Overall, these findings shed light on the significant association between cellular protein dopaminylation and cancer development, further suggesting that to block the installation of protein dopaminylation may become a promising anti-cancer strategy. TOC O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=106 SRC="FIGDIR/small/591460v1_ufig1.gif" ALT="Figure 1"> View larger version (24K): org.highwire.dtl.DTLVardef@1a3e9dorg.highwire.dtl.DTLVardef@104ecddorg.highwire.dtl.DTLVardef@5ab948org.highwire.dtl.DTLVardef@3a5d8b_HPS_FORMAT_FIGEXP M_FIG C_FIG
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 18
- FWCI
- 2.50
- Field percentile
- top 10%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Bioorthogonal labeling and enrichment of histone monoaminylation reveal its accumulation and regulatory function in cancer cell chromatin
Nan Zhang, Jinghua Wu, … Qingfei Zheng·Journal of the American Chemical SocietyPeer-reviewed·Jun 7, 2024
- Chemical Proteomic Profiling of the Histaminylation Proteome in Cancer Cells Unveils Uncharted Epigenetic Marks on Core Histones
Xingyu Ma, Anne A Leaman, … Qingfei Zheng·Journal of the American Chemical SocietyPeer-reviewed·Aug 3, 2026
- pH-Controlled chemoselective rapid azo-coupling reaction (CRACR) enables global profiling of serotonylation proteome in cancer cells
Nan Zhang, Jinghua Wu, … Qingfei Zheng·Journal of Proteome ResearchPeer-reviewed·Aug 29, 2024
- Deep proteomic analysis of Dnmt1 mutant/hypomorphic colorectal cancer cells reveals dys-regulation of Epithelial-Mesenchymal Transition and subcellular re-localization of Beta-Catenin
E. Bowler, A. Smith-Vidal, … R. M. Ewing·bioRxiv·Feb 13, 2019
- Histone monoaminylation dynamics are regulated by a single enzyme and promote neural rhythmicity
Qingfei Zheng, Ryan M. Bastle, … Ian S. Maze·bioRxiv·Dec 6, 2022
- Proteomics of Transglutaminase 2 polyaminated proteins
Don Benjamin, Danilo Ritz, … Michael N. Hall·bioRxiv·May 28, 2025